Similar articles

• Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD.

  Fozard JR, Hannon JP. Fozard JR, et al. Pulm Pharmacol Ther. 1999;12(2):111-4. doi: 10.1006/pupt.1999.0191. Pulm Pharmacol Ther. 1999. PMID: 10373392 Review. No abstract available.
• Role of adenosine in asthma.

  Feoktistov I, Biaggioni I. Feoktistov I, et al. Drug Dev Res. 1996;39:333-6. doi: 10.1002/(SICI)1098-2299(199611/12)39:3/4<333::AID-DDR14>3.0.CO;2-2. Drug Dev Res. 1996. PMID: 11542498
• Xanthines and Phosphodiesterase Inhibitors.

  Spina D, Page CP. Spina D, et al. Handb Exp Pharmacol. 2017;237:63-91. doi: 10.1007/164_2016_71. Handb Exp Pharmacol. 2017. PMID: 27844172 Review.
• Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.

  Vilsvik JS, Persson CG, Amundsen T, Brenna E, Naustdal T, Syvertsen U, Storstein L, Källén AG, Eriksson G, Holte S. Vilsvik JS, et al. Eur Respir J. 1990 Jan;3(1):27-32. Eur Respir J. 1990. PMID: 2311727 Clinical Trial.
• Asthma product guide.

  [No authors listed] [No authors listed] Community Nurse. 1997 Mar;3(2):16. Community Nurse. 1997. PMID: 9451111 No abstract available.